CIDRAP newsletters options
While the absolute risk of acquiring COVID-19 in the hospital was low—up to 0.75% risk per day of exposure pre-Delta (B1617.2) variant—patients or healthcare workers (HCWs) with COVID-19 nonetheless can be factors in the spread of COVID-19, a study published yesterday in PLOS One says.
This week Moderna plans to request a half-dose COVID-19 booster.
WHO leaders have previously urged countries to postpone broader use of booster doses.
Children may play a larger role in COVID-19 spread than previously thought.
An estimated 53.2 million additional cases of major depressive disorder and 76.2 million additional cases of anxiety disorders occurred during the pandemic, with women and young people most affected, according to a study published late last week in The Lancet.
In the weeks before the boy got sick, 3 of his neighbors—a father and 2 kids—died from a similar illness but weren't tested.
Emergency use authorization would be for treating mild to moderate COVID in adults at risk for severe disease.
While COVID rates were comparable, 52% of kids under 4 were asymptomatic, compared with 12% of adults.
People with mental disorders and intellectual disabilities had a greater mortality risk during the COVID-19 pandemic in 2020, according to a study published late last week in The Lancet Regional Health – Europe.
Implementing a set of rules targeting antimicrobial stewardship (AMS) into a hospital-wide medication review service was associated with a dramatic decline in inappropriate antibiotic prescribing, Belgian researchers reported last week in the Journal of Antimicrobial Chemotherapy.
Studies detail lower rates of routine vaccinations amid the pandemic, especially in kids.
Only 47% of teens are vaccinated, and in 9 states, less than a third of eligible teens are.
Also, surges continue in Europe, while some Asian countries see respite.
A clinical trial in the Netherlands found that an antimicrobial stewardship intervention safely reduced broad-spectrum antibiotic use in patients hospitalized with moderately severe pneumonia, Dutch researchers reported yesterday in The Lancet Infectious Diseases.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Female sex, middle age, two or more chronic diseases, and more severe initial illness were predictive of difficulty recovering from COVID-19 6 months after release from a hospital, finds a multicenter UK study yesterday in The Lancet Respiratory Medicine.
The trio of studies found that young men appear to have higher risk.
The FDA is slated to discuss the authorization during an Oct 26 meeting.
One study finds dramatically lower protection against infection—but not hospitalization or death—5 to 7 months after vaccination.
The plan aims to have 70% of each country's population vaccinated by mid-2022.